James R. Bidwell

Array ( [id] => 20471871 [patent_doc_number] => 20260014089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-15 [patent_title] => METHODS AND COMPOSITIONS FOR DENDRITIC CELL TARGETING NANO-DELIVERY [patent_app_type] => utility [patent_app_number] => 19/295121 [patent_app_country] => US [patent_app_date] => 2025-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19295121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20246801 [patent_doc_number] => 20250295670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-25 [patent_title] => METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION [patent_app_type] => utility [patent_app_number] => 19/230961 [patent_app_country] => US [patent_app_date] => 2025-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62655 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19230961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20231279 [patent_doc_number] => 20250288598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION [patent_app_type] => utility [patent_app_number] => 19/224452 [patent_app_country] => US [patent_app_date] => 2025-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20218574 [patent_doc_number] => 20250281505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION [patent_app_type] => utility [patent_app_number] => 19/216474 [patent_app_country] => US [patent_app_date] => 2025-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39997 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19216474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20163814 [patent_doc_number] => 20250255860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => ORAL FORMULATION OF A THERAPEUTIC COMPOUND [patent_app_type] => utility [patent_app_number] => 19/177269 [patent_app_country] => US [patent_app_date] => 2025-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1810 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19177269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20120407 [patent_doc_number] => 20250235438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-24 [patent_title] => OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITORI [patent_app_type] => utility [patent_app_number] => 19/174612 [patent_app_country] => US [patent_app_date] => 2025-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 131011 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19174612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19947059 [patent_doc_number] => 12318397 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-06-03 [patent_title] => Methods and compositions for testosterone production [patent_app_type] => utility [patent_app_number] => 19/025668 [patent_app_country] => US [patent_app_date] => 2025-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39947 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19025668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19845114 [patent_doc_number] => 20250090465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => Formulations of Enzalutamide [patent_app_type] => utility [patent_app_number] => 18/967829 [patent_app_country] => US [patent_app_date] => 2024-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18967829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19938960 [patent_doc_number] => 12311074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-27 [patent_title] => Burn wound treatment [patent_app_type] => utility [patent_app_number] => 18/962073 [patent_app_country] => US [patent_app_date] => 2024-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3674 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18962073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20031763 [patent_doc_number] => 20250169985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => DOUBLE-NETWORK VERSATILE HYDROGEL WITH ANTIBACTERIAL AND DRUG SEQUENTIAL RELEASE CAPABILITIES [patent_app_type] => utility [patent_app_number] => 18/913776 [patent_app_country] => US [patent_app_date] => 2024-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18913776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19875804 [patent_doc_number] => 20250108061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION [patent_app_type] => utility [patent_app_number] => 18/911121 [patent_app_country] => US [patent_app_date] => 2024-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18911121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19744074 [patent_doc_number] => 20250032639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF RNA [patent_app_type] => utility [patent_app_number] => 18/893280 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18585 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20239595 [patent_doc_number] => 12419899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-23 [patent_title] => Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin B [patent_app_type] => utility [patent_app_number] => 18/891739 [patent_app_country] => US [patent_app_date] => 2024-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 25325 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18891739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19650081 [patent_doc_number] => 12171841 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-12-24 [patent_title] => Synthesis and characterization of glauconite-based silicate nanorods as anticancer agent [patent_app_type] => utility [patent_app_number] => 18/778340 [patent_app_country] => US [patent_app_date] => 2024-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 10268 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18778340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19762143 [patent_doc_number] => 12220413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-11 [patent_title] => Magnetic nano-drug with double targeting VEGF-VEGFR, and preparation method and application thereof [patent_app_type] => utility [patent_app_number] => 18/765361 [patent_app_country] => US [patent_app_date] => 2024-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3585 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691116 [patent_doc_number] => 20250009661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => PLASMA COATING METHOD OF NANOVESICLE SURFACE AND PLASMA JET DEVICE FOR PLASMA COATING OF NANOVESICLE SURFACE [patent_app_type] => utility [patent_app_number] => 18/762860 [patent_app_country] => US [patent_app_date] => 2024-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18762860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784268 [patent_doc_number] => 20250057947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => USE OF TRIMANGANESE TETRAOXIDE PARTICLES IN PREPARATION OF VACCINE ADJUVANT [patent_app_type] => utility [patent_app_number] => 18/763977 [patent_app_country] => US [patent_app_date] => 2024-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18763977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19477366 [patent_doc_number] => 20240325408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => OLANZAPINE COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/736965 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18736965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19915178 [patent_doc_number] => 12290524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-06 [patent_title] => Methods and compositions for testosterone production [patent_app_type] => utility [patent_app_number] => 18/664867 [patent_app_country] => US [patent_app_date] => 2024-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 40285 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18664867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19674596 [patent_doc_number] => 12186434 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-07 [patent_title] => Surfactin-based lipopeptide for mRNA delivery [patent_app_type] => utility [patent_app_number] => 18/662099 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 6674 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662099 [rel_patent_id] =>[rel_patent_doc_number] =>)